跳到正文
Nature 干细胞主题·· 11 小时前AI 评分39

人iPSC来源肝类器官模型再现Wolman病多细胞组织反应并实现治疗性挽救

Human iPSC-derived liver organoid model multicellular tissue responses and therapeutic rescue in Wolman disease

AI 导读

研究利用人iPSC来源肝类器官模型再现Wolman病的多细胞组织反应,并实现治疗性挽救。人肝组织采集获意大利Friuli Venezia Giulia大区伦理委员会批准(protocol no. 0033969, 26 August 2024),参与者均签署书面知情同意;小鼠样本相关动物程序获CEEA-51伦理委员会批准(APAFIS no. 33620-2021101416506495)。

正文

Acknowledgments

The authors thank all the members of ADM lab at ICGEB for insightful discussions and Marco Bestagno from ICGEB for the technical support for the FACS analysis. Furthermore, we would like to thank Brassier Anaïs for helping in procuring patient samples. The figures in this work were created with BioRender (https://BioRender.com).

Funding

G.S. is funded by grants from: Telethon (GGP20031) and Italian Ministry of University and Research and European Union under NextGenerationEU “Progetti di rilevante interesse nazionale” (PRIN): PRIN prot. no.2022PWKZXE; PNRR M4C2 INV 1.1, PRIN 2022 prot. no. P2022A9J9L; NRRP NextGenerationEU Project CN00000041-National Center for Gene Therapy and Drugs based on RNA Technology; AIRC (Start-Up 2020 – ID. 24322 project – PI G.S.). M.A. is funded by the French National Research Agency (grants: NEEDED ANR -24-CE18-3712-01). This study was partially funded by the Italian Ministry of University and Research (MUR) program, “Departments of Excellence 2023–2027”, the AGING Project—Department of Translational Medicine, University of Piemonte Orientale, and is part of the project, P2022E3BTH-CUP C53D23007600001, which received funding from NextGeneration EU-MUR M4C2–PRIN 2022 PNRR. G.D.S. is funded by the Fondazione AIRC IG grant 30570, the Fondazione AIRC Special Program Molecular Clinical Oncology “5 per mille” 22759, Worldwide Cancer Research (grant 24-0361), the NRRP NextGenerationEU Project CN00000041-National Center for Gene Therapy and Drugs based on RNA Technology, the Italian University and Research Ministry PRIN P2022ZWY8H and the PRIN 2022XBYNJP. R.B. was supported by an AIRC post-doc fellowship for Italy (ID: 29960).

Author information

Authors and Affiliations

  1. International Centre for Genetic Engineering and Biotechnology (ICGEB), Laboratory of Advanced Disease Models, Area Science Park- Padriciano, Trieste, Italy

    Davide Selvestrel, Caterina Da Rodda, Beatrice Anfuso, Suresh Velnati, Karin Hofmann & Giovanni Sorrentino

  2. Genethon, 91000, Evry, France

    Marine Laurent & Mario Amendola

  3. Paris-Saclay University, Univ Evry, Inserm, Genethon, Integrate research unit UMR_S951, 91000, Evry, France

    Marine Laurent & Mario Amendola

  4. Department of Translational Medicine (DIMET), Center of Excellence in Aging Sciences, University of Piemonte Orientale, Novara, Italy

    Annamaria Antona, Marcello Manfredi & Daniela Capello

  5. Armenise-Harvard Laboratory of Cell Division, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy

    Alessia Mattivi & Luca Fava

  6. Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy

    Andrea Marfoglia, Deborah Bonazza, Fabrizio Zanconati, Manuela Mastronardi, Nicolò de Manzini, Silvia Palmisano & Giovanni Sorrentino

  7. International Centre for Genetic Engineering and Biotechnology (ICGEB), Laboratory of Cancer Cell Signaling, Area Science Park- Padriciano, Trieste, Italy

    Rebecca Bertolio & Giannino Del Sal

  8. Laboratory of stem cell biology, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy

    Luciano Conti

  9. Department of Pathology, University Hospital Cattinara, Trieste, Italy

    Deborah Bonazza & Fabrizio Zanconati

  10. Surgical Clinic Unit, Cattinara Hospital, ASUGI, Strada di Fiume, 447, Trieste, Italy

    Manuela Mastronardi, Nicolò de Manzini & Silvia Palmisano

  11. Fondazione Italiana Fegato, Trieste, Italy

    Natalia Rosso & Claudio Tiribelli

  12. Center for Translational Research on Autoimmune and Allergic Diseases, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy

    Marcello Manfredi

  13. UPO Biobank, University of Piemonte Orientale, Novara, Italy

    Daniela Capello

  14. Department of Medical Pathology and Biology, Paris Hospitals Public Assistance, Hôpital Necker, University Paris Cité, Paris, France

    Philippe Drabent

  15. Department of Life Sciences, University of Trieste, Trieste, Italy

    Giannino Del Sal

  16. IFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy

    Giannino Del Sal

  17. Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy

    Mario Amendola

Authors

  1. Davide Selvestrel
  2. Caterina Da Rodda
  3. Beatrice Anfuso
  4. Marine Laurent
  5. Annamaria Antona
  6. Alessia Mattivi
  7. Suresh Velnati
  8. Karin Hofmann
  9. Andrea Marfoglia
  10. Rebecca Bertolio
  11. Luciano Conti
  12. Deborah Bonazza
  13. Fabrizio Zanconati
  14. Manuela Mastronardi
  15. Nicolò de Manzini
  16. Natalia Rosso
  17. Claudio Tiribelli
  18. Marcello Manfredi
  19. Daniela Capello
  20. Philippe Drabent
  21. Luca Fava
  22. Silvia Palmisano
  23. Giannino Del Sal
  24. Mario Amendola
  25. Giovanni Sorrentino

Corresponding author

Correspondence to Giovanni Sorrentino.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

All methods were performed in accordance with the relevant guidelines and regulations. The collection and use of human liver tissue for the generation of organotypic cultures were approved by the Comitato Etico Unico Regionale of Friuli Venezia Giulia, Italy (protocol no. 0033969, 26 August 2024). Written informed consent was obtained from all participants. All animal procedures from which the mouse samples used in this study were derived were approved by the ethical committee CEEA-51 (APAFIS no. 33620-2021101416506495) and were performed in accordance with French and European legislation governing animal experimentation. No identifiable images of human research participants are included in this article; therefore, separate consent for publication of identifiable images was not required.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Edited by Dr Giovanni Blandino

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Selvestrel, D., Da Rodda, C., Anfuso, B. et al. Human iPSC-derived liver organoid model multicellular tissue responses and therapeutic rescue in Wolman disease. Cell Death Dis (2026). https://doi.org/10.1038/s41419-026-09345-1

Download citation

  • Received: 06 July 2026

  • Revised: 08 September 2026

  • Accepted: 27 September 2026

  • Published: 16 October 2026

  • DOI: https://doi.org/10.1038/s41419-026-09345-1

来源:Nature 干细胞主题 · nature.com